Literature DB >> 10811710

Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome.

B Turner1, A J Wills.   

Abstract

Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. However, treatment is expensive and side effects may be severe. A patient with Miller Fisher syndrome who developed cortical blindness as a consequence of occipital infarction precipitated by IVIg is reported on.

Entities:  

Mesh：

Year:  2000        PMID： 10811710      PMCID： PMC1736949          DOI： 10.1136/jnnp.68.6.790

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  4 in total

Review 1.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Intravenous immunoglobulin in lupus panniculitis.

Authors:  João Espírito Santo; M F Gomes; M J Gomes; L Peixoto; S C Pereira; A Acabado; J Freitas; G Vinhas de Sousa
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 3.  On the dark side of therapies with immunoglobulin concentrates: the adverse events.

Authors:  Peter J Späth; Guido Granata; Fabiola La Marra; Taco W Kuijpers; Isabella Quinti
Journal:  Front Immunol       Date:  2015-02-05       Impact factor: 7.561

4.  Polyradiculitis and encephalomyelitis in the same patient following a SARS-CoV-2 vaccination.

Authors:  Josef Finsterer
Journal:  Neurol Res Pract       Date:  2022-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.